Patterns and trends of potentially inappropriate high-density lipoprotein cholesterol testing in Australian adults at high risk of cardiovascular disease from 2008 to 2014: analysis of linked individual patient data from the Australian Medicare Benefits Schedule and Pharmaceutical Benefits Scheme

OBJECTIVES: We examine the extent to which the adult Australian population on lipid-lowering medications receives the level of high-density lipoprotein cholesterol (HDL-C) testing recommended by national guidelines. DATA: We analysed records from 7 years (2008–2014) of the 10% publicly available sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajati, Farshid, Atlantis, Evan, Bell, Katy J L, Girosi, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855213/
https://www.ncbi.nlm.nih.gov/pubmed/29523561
http://dx.doi.org/10.1136/bmjopen-2017-019041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855213/
https://www.ncbi.nlm.nih.gov/pubmed/29523561
http://dx.doi.org/10.1136/bmjopen-2017-019041

Ejemplares similares